Literature DB >> 11430514

Risk of stillbirth in offspring of men exposed to ionising radiation.

S Abrahamson1, E J Tawn.   

Abstract

Radiation genetic risk models are employed to predict the frequency of radiation-related stillbirths to partners of occupationally exposed male workers, using the incidence data recently reported by Parker et al from an epidemiological study of Cumbrian births. Expanding on previously developed conservative risk estimates suggests that, of the 130 observed stillbirths to partners of male radiation workers, 0.3 cases would be attributable to paternal preconceptional irradiation, in contrast to the 17.5 (95% confidence interval: 3.1 to 31.9) cases predicted by Parker et al from their preferred dose-response model. The incompatibility of the results reported by Parker et al with those from other investigations, both epidemiological and experimental, and the inability of the study to consider a number of factors which might affect stillbirth rates, particularly those relating to the mother, make it difficult to accept that paternal irradiation received occupationally could have contributed to a detectable increase in stillbirths.

Entities:  

Mesh:

Year:  2001        PMID: 11430514     DOI: 10.1088/0952-4746/21/2/303

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  2 in total

1.  Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study.

Authors:  Lisa B Signorello; John J Mulvihill; Daniel M Green; Heather M Munro; Marilyn Stovall; Rita E Weathers; Ann C Mertens; John A Whitton; Leslie L Robison; John D Boice
Journal:  Lancet       Date:  2010-07-23       Impact factor: 79.321

2.  The Likelihood of Adverse Pregnancy Outcomes and Genetic Disease (Transgenerational Effects) from Exposure to Radioactive Fallout from the 1945 Trinity Atomic Bomb Test.

Authors:  John D Boice
Journal:  Health Phys       Date:  2020-10       Impact factor: 2.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.